117 related articles for article (PubMed ID: 28421714)
1. Endometrial cells on Pap tests: ideal reporting is more complex than just finding the right age.
Fischer G; Haddad M; Cormier K
Diagn Cytopathol; 2017 Jul; 45(7):587-591. PubMed ID: 28421714
[TBL] [Abstract][Full Text] [Related]
2. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
[TBL] [Abstract][Full Text] [Related]
3. Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates.
Izadi-Mood N; Sarmadi S; Sanii S; Sadidi H
Acta Cytol; 2015; 59(2):175-9. PubMed ID: 25924690
[TBL] [Abstract][Full Text] [Related]
4. Reporting of Benign Endometrial Cells in Papanicolaou Tests.
Hernandez A; Schatz-Siemers N; Zhou F; Brandler TC; Negron R; Modi L; Elgert PA; Simsir A
Am J Clin Pathol; 2020 Aug; 154(3):381-386. PubMed ID: 32405650
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy.
Visser NC; Sparidaens EM; van den Brink JW; Breijer MC; Boss EA; Veersema S; Siebers AG; Bulten J; Pijnenborg JM; Bekkers RL
Acta Obstet Gynecol Scand; 2016 Dec; 95(12):1418-1424. PubMed ID: 27633936
[TBL] [Abstract][Full Text] [Related]
6. Significance of endometrial cells in cervical cytology.
Yu EJ; Park NH; Song YS; Lee YK
J Obstet Gynaecol; 2016 Oct; 36(7):966-969. PubMed ID: 27560859
[TBL] [Abstract][Full Text] [Related]
7. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years.
Weiss VL; Cate F; Bloom L; Fadare O; Coogan AC; Desouki MM
Cytopathology; 2016 Aug; 27(4):242-8. PubMed ID: 26689647
[TBL] [Abstract][Full Text] [Related]
8. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001.
Simsir A; Carter W; Elgert P; Cangiarella J
Am J Clin Pathol; 2005 Apr; 123(4):571-5. PubMed ID: 15743742
[TBL] [Abstract][Full Text] [Related]
9. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
[TBL] [Abstract][Full Text] [Related]
10. Age cutoff for reporting of benign-appearing endometrial cells in Papanicolaou specimens; should it be raised? A 10-year retrospective study from a large county hospital.
Hinson S; Molberg K; Mir M; Flores M; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(2):78-83. PubMed ID: 31287423
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older.
Keleş E; Öztürk UK; Alinca CM; Akiş S; Kabaca C; Çetiner H
Turk Patoloji Derg; 2022; 38(3):235-239. PubMed ID: 35147975
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of benign endometrial cells in postmenopausal women.
Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Significance of Endometrial Cells Detected on Pap Testing: The Impact of Revisions to the 3rd Edition of the Bethesda System for Reporting Cervical Cytology.
Morikawa LH; Tauchi-Nishi PS
Ann Clin Lab Sci; 2017 May; 47(3):298-305. PubMed ID: 28667030
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.
Saad RS; Takei H; Liu YL; Silverman JE; Lipscomb JT; Ruiz B
Acta Cytol; 2006; 50(1):48-54. PubMed ID: 16514840
[TBL] [Abstract][Full Text] [Related]
15. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.
Gomez-Fernandez CR; Ganjei-Azar P; Behshid K; Averette HE; Nadji M
Obstet Gynecol; 2000 Dec; 96(6):874-8. PubMed ID: 11084170
[TBL] [Abstract][Full Text] [Related]
16. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
17. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
18. Significance of atypical endometrial cells in women younger than 40 years of age.
Yuan L; Biscotti CV; Zhu H; Booth CN; Abdul-Karim FW; Zhang Y
J Am Soc Cytopathol; 2020; 9(1):33-37. PubMed ID: 31353256
[TBL] [Abstract][Full Text] [Related]
19. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Age Cutoff Criterion for Reporting Benign-Appearing Endometrial Cells in Routine Pap Tests: An 8-Year Retrospective Review.
Grada Z; Paquette C; Eklund CM; Zhang C; Sung CJ; Steinhoff M; Quddus MR
Acta Cytol; 2017; 61(3):194-198. PubMed ID: 28486237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
